nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Sorafenib—liver cancer	0.526	1	CbGbCtD
Testosterone Propionate—Oligospermia—Epirubicin—liver cancer	0.00634	0.0389	CcSEcCtD
Testosterone Propionate—Oligospermia—Doxorubicin—liver cancer	0.00587	0.036	CcSEcCtD
Testosterone Propionate—Azoospermia—Epirubicin—liver cancer	0.00493	0.0303	CcSEcCtD
Testosterone Propionate—Azoospermia—Doxorubicin—liver cancer	0.00457	0.028	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Sorafenib—liver cancer	0.00434	0.0266	CcSEcCtD
Testosterone Propionate—Neoplasm—Sorafenib—liver cancer	0.00325	0.0199	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Sorafenib—liver cancer	0.00322	0.0197	CcSEcCtD
Testosterone Propionate—Vesiculobullous rash—Epirubicin—liver cancer	0.00237	0.0145	CcSEcCtD
Testosterone Propionate—Breast disorder—Sorafenib—liver cancer	0.00236	0.0145	CcSEcCtD
Testosterone Propionate—Vesiculobullous rash—Doxorubicin—liver cancer	0.00219	0.0135	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Sorafenib—liver cancer	0.00208	0.0127	CcSEcCtD
Testosterone Propionate—Ethynodiol—ESR1—liver cancer	0.00197	0.206	CrCbGaD
Testosterone Propionate—Seborrhoeic dermatitis—Epirubicin—liver cancer	0.00195	0.012	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Sorafenib—liver cancer	0.0019	0.0117	CcSEcCtD
Testosterone Propionate—Haemoglobin—Sorafenib—liver cancer	0.00182	0.0111	CcSEcCtD
Testosterone Propionate—Haemorrhage—Sorafenib—liver cancer	0.00181	0.0111	CcSEcCtD
Testosterone Propionate—Seborrhoeic dermatitis—Doxorubicin—liver cancer	0.0018	0.0111	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Sorafenib—liver cancer	0.00178	0.0109	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Sorafenib—liver cancer	0.00177	0.0109	CcSEcCtD
Testosterone Propionate—Urethral disorder—Sorafenib—liver cancer	0.00177	0.0109	CcSEcCtD
Testosterone Propionate—Norgestimate—ESR1—liver cancer	0.00167	0.175	CrCbGaD
Testosterone Propionate—Rash pustular—Epirubicin—liver cancer	0.00167	0.0102	CcSEcCtD
Testosterone Propionate—Angiopathy—Sorafenib—liver cancer	0.00164	0.01	CcSEcCtD
Testosterone Propionate—Immune system disorder—Sorafenib—liver cancer	0.00163	0.01	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Sorafenib—liver cancer	0.00163	0.00998	CcSEcCtD
Testosterone Propionate—Alopecia—Sorafenib—liver cancer	0.0016	0.00979	CcSEcCtD
Testosterone Propionate—Mental disorder—Sorafenib—liver cancer	0.00158	0.0097	CcSEcCtD
Testosterone Propionate—Malnutrition—Sorafenib—liver cancer	0.00157	0.00964	CcSEcCtD
Testosterone Propionate—Rash pustular—Doxorubicin—liver cancer	0.00154	0.00946	CcSEcCtD
Testosterone Propionate—Breast pain—Epirubicin—liver cancer	0.00152	0.00934	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Epirubicin—liver cancer	0.00151	0.00928	CcSEcCtD
Testosterone Propionate—Breast pain—Doxorubicin—liver cancer	0.00141	0.00864	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Doxorubicin—liver cancer	0.0014	0.00858	CcSEcCtD
Testosterone Propionate—Inflammation—Epirubicin—liver cancer	0.00137	0.0084	CcSEcCtD
Testosterone Propionate—Hypertension—Sorafenib—liver cancer	0.00136	0.00832	CcSEcCtD
Testosterone Propionate—Arthralgia—Sorafenib—liver cancer	0.00134	0.00821	CcSEcCtD
Testosterone Propionate—Myalgia—Sorafenib—liver cancer	0.00134	0.00821	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00133	0.00815	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Sorafenib—liver cancer	0.00128	0.00787	CcSEcCtD
Testosterone Propionate—Inflammation—Doxorubicin—liver cancer	0.00127	0.00778	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Sorafenib—liver cancer	0.00126	0.00772	CcSEcCtD
Testosterone Propionate—Skin disorder—Sorafenib—liver cancer	0.00125	0.00764	CcSEcCtD
Testosterone Propionate—Neoplasm—Epirubicin—liver cancer	0.0012	0.00737	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00117	0.00717	CcSEcCtD
Testosterone Propionate—Dyspnoea—Sorafenib—liver cancer	0.00114	0.00702	CcSEcCtD
Testosterone Propionate—Neoplasm—Doxorubicin—liver cancer	0.00111	0.00682	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Sorafenib—liver cancer	0.00111	0.00679	CcSEcCtD
Testosterone Propionate—Fatigue—Sorafenib—liver cancer	0.00111	0.00678	CcSEcCtD
Testosterone Propionate—Pain—Sorafenib—liver cancer	0.0011	0.00673	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Sorafenib—liver cancer	0.00105	0.00643	CcSEcCtD
Testosterone Propionate—Increased appetite—Epirubicin—liver cancer	0.00103	0.0063	CcSEcCtD
Testosterone Propionate—Levonorgestrel—ESR1—liver cancer	0.00103	0.107	CrCbGaD
Testosterone Propionate—Urticaria—Sorafenib—liver cancer	0.00102	0.00625	CcSEcCtD
Testosterone Propionate—Abdominal pain—Sorafenib—liver cancer	0.00101	0.00622	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Epirubicin—liver cancer	0.00101	0.00619	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—liver cancer	0.000997	0.00611	CcSEcCtD
Testosterone Propionate—Fluoxymesterone—ESR1—liver cancer	0.000977	0.102	CrCbGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000965	0.00592	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—liver cancer	0.00095	0.00583	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Sorafenib—liver cancer	0.000945	0.0058	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—liver cancer	0.000934	0.00573	CcSEcCtD
Testosterone Propionate—Danazol—ESR1—liver cancer	0.000934	0.0975	CrCbGaD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000922	0.00566	CcSEcCtD
Testosterone Propionate—Asthenia—Sorafenib—liver cancer	0.000921	0.00565	CcSEcCtD
Testosterone Propionate—Pruritus—Sorafenib—liver cancer	0.000908	0.00557	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000893	0.00547	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—liver cancer	0.000891	0.00546	CcSEcCtD
Testosterone Propionate—Diarrhoea—Sorafenib—liver cancer	0.000878	0.00538	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—liver cancer	0.000872	0.00535	CcSEcCtD
Testosterone Propionate—Dizziness—Sorafenib—liver cancer	0.000848	0.0052	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—liver cancer	0.000838	0.0875	CrCbGaD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—liver cancer	0.000824	0.00505	CcSEcCtD
Testosterone Propionate—Vomiting—Sorafenib—liver cancer	0.000816	0.005	CcSEcCtD
Testosterone Propionate—Rash—Sorafenib—liver cancer	0.000809	0.00496	CcSEcCtD
Testosterone Propionate—Dermatitis—Sorafenib—liver cancer	0.000808	0.00496	CcSEcCtD
Testosterone Propionate—Breast disorder—Doxorubicin—liver cancer	0.000807	0.00495	CcSEcCtD
Testosterone Propionate—Headache—Sorafenib—liver cancer	0.000804	0.00493	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—liver cancer	0.00078	0.00478	CcSEcCtD
Testosterone Propionate—Nausea—Sorafenib—liver cancer	0.000762	0.00467	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—liver cancer	0.000759	0.00465	CcSEcCtD
Testosterone Propionate—Dysuria—Doxorubicin—liver cancer	0.000721	0.00442	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—liver cancer	0.000709	0.00435	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—liver cancer	0.000703	0.00431	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—liver cancer	0.000702	0.00431	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—liver cancer	0.000683	0.00227	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000682	0.00227	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—JUN—liver cancer	0.00068	0.00226	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GPX3—liver cancer	0.000678	0.00225	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CDKN1B—liver cancer	0.000678	0.00225	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Epirubicin—liver cancer	0.000671	0.00411	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000669	0.00222	CbGpPWpGaD
Testosterone Propionate—Haemorrhage—Epirubicin—liver cancer	0.000667	0.00409	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—liver cancer	0.000667	0.00221	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Epirubicin—liver cancer	0.000659	0.00404	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—liver cancer	0.000658	0.00218	CbGpPWpGaD
Testosterone Propionate—Haematuria—Doxorubicin—liver cancer	0.000656	0.00402	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—liver cancer	0.000656	0.00402	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—liver cancer	0.000654	0.00401	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—liver cancer	0.000651	0.00399	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—HPGDS—liver cancer	0.000647	0.00215	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.000645	0.00214	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—liver cancer	0.000639	0.00212	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP1A1—liver cancer	0.000632	0.0021	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—liver cancer	0.00063	0.00209	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A1—liver cancer	0.000623	0.00207	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CDKN2A—liver cancer	0.000621	0.00206	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Doxorubicin—liver cancer	0.000621	0.00381	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—liver cancer	0.000618	0.00379	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000616	0.00204	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—liver cancer	0.000616	0.00204	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—liver cancer	0.000614	0.00204	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000613	0.00203	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—liver cancer	0.00061	0.00374	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—liver cancer	0.000607	0.00372	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—liver cancer	0.000606	0.00371	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A1—liver cancer	0.000605	0.00201	CbGpPWpGaD
Testosterone Propionate—Urethral disorder—Doxorubicin—liver cancer	0.000605	0.00371	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—liver cancer	0.000603	0.0037	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—liver cancer	0.000601	0.00369	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.0006	0.00199	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000597	0.00198	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000594	0.00197	CbGpPWpGaD
Testosterone Propionate—Alopecia—Epirubicin—liver cancer	0.00059	0.00362	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—JUN—liver cancer	0.000586	0.00195	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Epirubicin—liver cancer	0.000585	0.00359	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000583	0.00194	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Epirubicin—liver cancer	0.000581	0.00356	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—liver cancer	0.000568	0.00189	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—liver cancer	0.000567	0.00188	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—liver cancer	0.00056	0.00344	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—liver cancer	0.000558	0.00185	CbGpPWpGaD
Testosterone Propionate—Immune system disorder—Doxorubicin—liver cancer	0.000558	0.00342	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—liver cancer	0.000557	0.00341	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.000555	0.00184	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GGT1—liver cancer	0.000552	0.00183	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—liver cancer	0.000546	0.00181	CbGpPWpGaD
Testosterone Propionate—Alopecia—Doxorubicin—liver cancer	0.000546	0.00335	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—liver cancer	0.000541	0.00332	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Epirubicin—liver cancer	0.000539	0.00331	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—liver cancer	0.000538	0.0033	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.000531	0.00176	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00053	0.00176	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2E1—liver cancer	0.000527	0.00175	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—liver cancer	0.000525	0.00174	CbGpPWpGaD
Testosterone Propionate—Malaise—Epirubicin—liver cancer	0.000524	0.00321	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00052	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—liver cancer	0.00052	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—liver cancer	0.000502	0.00167	CbGpPWpGaD
Testosterone Propionate—Hypertension—Epirubicin—liver cancer	0.000502	0.00308	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—liver cancer	0.0005	0.00166	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—liver cancer	0.000499	0.00306	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NR1H4—liver cancer	0.000498	0.00165	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—liver cancer	0.000496	0.00165	CbGpPWpGaD
Testosterone Propionate—Myalgia—Epirubicin—liver cancer	0.000495	0.00303	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—liver cancer	0.000495	0.00303	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—liver cancer	0.000493	0.00302	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000491	0.00301	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NR1I3—liver cancer	0.000489	0.00162	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—HMOX1—liver cancer	0.000489	0.00162	CbGpPWpGaD
Testosterone Propionate—Discomfort—Epirubicin—liver cancer	0.000489	0.003	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—liver cancer	0.000485	0.00297	CcSEcCtD
Testosterone Propionate—Progesterone—ESR1—liver cancer	0.000484	0.0505	CrCbGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GGT1—liver cancer	0.000484	0.00161	CbGpPWpGaD
Testosterone Propionate—Confusional state—Epirubicin—liver cancer	0.000478	0.00293	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—liver cancer	0.000474	0.00291	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—liver cancer	0.000474	0.00291	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—UGDH—liver cancer	0.000473	0.00157	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000468	0.00155	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—liver cancer	0.000465	0.00285	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—liver cancer	0.000464	0.00285	CcSEcCtD
Testosterone Propionate—Skin disorder—Epirubicin—liver cancer	0.000461	0.00282	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—liver cancer	0.000458	0.00281	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—liver cancer	0.000458	0.00281	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—liver cancer	0.000456	0.0028	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—HGF—liver cancer	0.000455	0.00151	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—liver cancer	0.000455	0.00151	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000455	0.00279	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000454	0.00151	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—UGDH—liver cancer	0.000453	0.0015	CbGpPWpGaD
Testosterone Propionate—Discomfort—Doxorubicin—liver cancer	0.000452	0.00277	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—EPT1—liver cancer	0.000445	0.00148	CbGpPWpGaD
Testosterone Propionate—Confusional state—Doxorubicin—liver cancer	0.000442	0.00271	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00044	0.00146	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—liver cancer	0.000439	0.00269	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—liver cancer	0.000439	0.00269	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000437	0.00145	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—liver cancer	0.000435	0.00144	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000432	0.00265	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—liver cancer	0.00043	0.00264	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—liver cancer	0.000429	0.00263	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—liver cancer	0.000429	0.00142	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—liver cancer	0.000426	0.00261	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—liver cancer	0.000426	0.00261	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—EPT1—liver cancer	0.000426	0.00141	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Epirubicin—liver cancer	0.000423	0.00259	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—liver cancer	0.000423	0.0014	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—liver cancer	0.000422	0.0014	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TAT—liver cancer	0.000421	0.0014	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—liver cancer	0.000418	0.00139	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000417	0.00139	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BRAF—liver cancer	0.000413	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—liver cancer	0.00041	0.00136	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000409	0.00251	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—liver cancer	0.000409	0.00251	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—liver cancer	0.000405	0.00249	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000405	0.00134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TAT—liver cancer	0.000404	0.00134	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0004	0.00245	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—liver cancer	0.000399	0.00133	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000397	0.00132	CbGpPWpGaD
Testosterone Propionate—Insomnia—Doxorubicin—liver cancer	0.000397	0.00243	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—liver cancer	0.000394	0.00131	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Doxorubicin—liver cancer	0.000394	0.00242	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.000392	0.0013	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Doxorubicin—liver cancer	0.000391	0.0024	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—liver cancer	0.000391	0.0024	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—liver cancer	0.000388	0.00129	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—liver cancer	0.000388	0.00238	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—JUN—liver cancer	0.000387	0.00129	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A1—liver cancer	0.000387	0.0404	CrCbGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—liver cancer	0.000384	0.00128	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000379	0.00232	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A1—liver cancer	0.000379	0.00126	CbGpPWpGaD
Testosterone Propionate—Fatigue—Doxorubicin—liver cancer	0.000378	0.00232	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000377	0.00125	CbGpPWpGaD
Testosterone Propionate—Urticaria—Epirubicin—liver cancer	0.000377	0.00231	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CDKN1A—liver cancer	0.000375	0.00125	CbGpPWpGaD
Testosterone Propionate—Pain—Doxorubicin—liver cancer	0.000375	0.0023	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—liver cancer	0.000375	0.0023	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A1—liver cancer	0.000374	0.00124	CbGpPWpGaD
Testosterone Propionate—Norethindrone—ALB—liver cancer	0.00037	0.0386	CrCbGaD
Testosterone Propionate—Testosterone—CYP1A1—liver cancer	0.000366	0.0382	CrCbGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—liver cancer	0.000362	0.00222	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000359	0.0022	CcSEcCtD
Testosterone Propionate—Methyltestosterone—ALB—liver cancer	0.000351	0.0367	CrCbGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—liver cancer	0.000349	0.00214	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—liver cancer	0.000349	0.00214	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000348	0.00116	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—liver cancer	0.000347	0.00213	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—RAF1—liver cancer	0.000344	0.00114	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000341	0.00113	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—liver cancer	0.00034	0.00209	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—HNF4A—liver cancer	0.000339	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—liver cancer	0.000339	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000336	0.00111	CbGpPWpGaD
Testosterone Propionate—Pruritus—Epirubicin—liver cancer	0.000335	0.00206	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—liver cancer	0.000335	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000331	0.0011	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000325	0.00108	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—liver cancer	0.000324	0.00199	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Doxorubicin—liver cancer	0.000323	0.00198	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—BRAF—liver cancer	0.000316	0.00105	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—liver cancer	0.000315	0.00193	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—liver cancer	0.000314	0.00192	CcSEcCtD
Testosterone Propionate—Pruritus—Doxorubicin—liver cancer	0.00031	0.0019	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000307	0.00102	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—liver cancer	0.000301	0.00185	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—EXOSC2—liver cancer	0.000301	0.000999	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Doxorubicin—liver cancer	0.0003	0.00184	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—liver cancer	0.000299	0.00183	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—liver cancer	0.000299	0.00183	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000297	0.000986	CbGpPWpGaD
Testosterone Propionate—Headache—Epirubicin—liver cancer	0.000297	0.00182	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—liver cancer	0.000292	0.000969	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—liver cancer	0.00029	0.00178	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GLUL—liver cancer	0.000286	0.000951	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CPT1B—liver cancer	0.000286	0.000951	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000284	0.000943	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—UGDH—liver cancer	0.000283	0.00094	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—liver cancer	0.000282	0.00173	CcSEcCtD
Testosterone Propionate—Vomiting—Doxorubicin—liver cancer	0.000279	0.00171	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—liver cancer	0.000277	0.0017	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—liver cancer	0.000276	0.0017	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NR1H4—liver cancer	0.000276	0.000917	CbGpPWpGaD
Testosterone Propionate—Headache—Doxorubicin—liver cancer	0.000275	0.00169	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GLUL—liver cancer	0.000274	0.000911	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CPT1B—liver cancer	0.000274	0.000911	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTA3—liver cancer	0.000272	0.000902	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EPT1—liver cancer	0.000266	0.000884	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NR1H4—liver cancer	0.000265	0.000878	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—RAF1—liver cancer	0.000264	0.000876	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000261	0.000867	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—liver cancer	0.000261	0.0016	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GSTA3—liver cancer	0.00026	0.000863	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000254	0.000845	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000254	0.000844	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000254	0.000842	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TAT—liver cancer	0.000252	0.000838	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000252	0.000836	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTA4—liver cancer	0.000248	0.000825	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—JUN—liver cancer	0.000247	0.00082	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000245	0.000814	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTA2—liver cancer	0.000242	0.000804	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000241	0.0008	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR1H4—liver cancer	0.00024	0.000795	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTA4—liver cancer	0.000238	0.00079	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR1I3—liver cancer	0.000235	0.000782	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTA1—liver cancer	0.000234	0.000775	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000233	0.000773	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000232	0.000772	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTA2—liver cancer	0.000232	0.00077	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NAT2—liver cancer	0.000231	0.000767	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTA1—liver cancer	0.000224	0.000742	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000222	0.000736	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALDOB—liver cancer	0.000221	0.000735	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NAT2—liver cancer	0.000221	0.000734	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000221	0.000733	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000216	0.000718	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000216	0.000717	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.000216	0.000717	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000213	0.000706	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALDOB—liver cancer	0.000212	0.000704	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CRABP1—liver cancer	0.000211	0.000701	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000211	0.000699	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00021	0.000698	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000209	0.000692	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000204	0.000677	CbGpPWpGaD
Testosterone Propionate—Testosterone—ALB—liver cancer	0.000204	0.0213	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000204	0.000676	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CRABP1—liver cancer	0.000202	0.000671	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000199	0.00066	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—liver cancer	0.00019	0.00063	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000188	0.000625	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—liver cancer	0.000186	0.000616	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—liver cancer	0.000185	0.000614	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HPGDS—liver cancer	0.000185	0.000613	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000184	0.00061	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000182	0.000605	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARA—liver cancer	0.000178	0.000591	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HPGDS—liver cancer	0.000177	0.000587	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000176	0.000583	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GLUL—liver cancer	0.000172	0.00057	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CPT1B—liver cancer	0.000172	0.00057	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000169	0.000561	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000169	0.00056	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000167	0.000556	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NR1H4—liver cancer	0.000165	0.000549	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSMA4—liver cancer	0.000165	0.000546	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PSMD10—liver cancer	0.000165	0.000546	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HNF4A—liver cancer	0.000163	0.000542	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTA3—liver cancer	0.000163	0.00054	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—liver cancer	0.000161	0.000536	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00016	0.000531	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GOT2—liver cancer	0.00016	0.000531	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000158	0.000525	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSMA4—liver cancer	0.000158	0.000523	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PSMD10—liver cancer	0.000158	0.000523	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000157	0.000522	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000156	0.000518	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GOT2—liver cancer	0.000153	0.000509	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2E1—liver cancer	0.00015	0.0005	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—liver cancer	0.000149	0.000496	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTA4—liver cancer	0.000149	0.000494	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—liver cancer	0.000147	0.000489	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—liver cancer	0.000145	0.000482	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTA2—liver cancer	0.000145	0.000481	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2E1—liver cancer	0.000144	0.000478	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000143	0.000476	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSMA4—liver cancer	0.000143	0.000474	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PSMD10—liver cancer	0.000143	0.000474	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000141	0.000469	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYCS—liver cancer	0.000141	0.000467	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTA1—liver cancer	0.00014	0.000464	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00014	0.000463	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000139	0.000461	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NAT2—liver cancer	0.000138	0.000459	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GGT1—liver cancer	0.000138	0.000459	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GOT1—liver cancer	0.000138	0.000459	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYCS—liver cancer	0.000135	0.000448	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALDOB—liver cancer	0.000133	0.00044	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—SERPINE1—liver cancer	0.000133	0.00044	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GGT1—liver cancer	0.000132	0.000439	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GOT1—liver cancer	0.000132	0.000439	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CRABP1—liver cancer	0.000127	0.00042	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—liver cancer	0.000124	0.000412	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HMOX1—liver cancer	0.000122	0.000406	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—liver cancer	0.000119	0.000395	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMOX1—liver cancer	0.000117	0.000389	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000117	0.000389	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—liver cancer	0.000114	0.000379	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HPGDS—liver cancer	0.000111	0.000367	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—liver cancer	0.000109	0.000363	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A1—liver cancer	0.000108	0.000359	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A1—liver cancer	0.000104	0.000344	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—liver cancer	0.000101	0.000335	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARA—liver cancer	9.89e-05	0.000328	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSMD10—liver cancer	9.86e-05	0.000327	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PSMA4—liver cancer	9.86e-05	0.000327	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—liver cancer	9.65e-05	0.00032	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—H2AFX—liver cancer	9.64e-05	0.00032	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GOT2—liver cancer	9.59e-05	0.000318	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARA—liver cancer	9.47e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2E1—liver cancer	9.01e-05	0.000299	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARA—liver cancer	8.57e-05	0.000285	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.51e-05	0.000282	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CG—liver cancer	8.47e-05	0.000281	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYCS—liver cancer	8.43e-05	0.00028	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—liver cancer	8.39e-05	0.000279	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GOT1—liver cancer	8.28e-05	0.000275	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GGT1—liver cancer	8.28e-05	0.000275	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—liver cancer	8.17e-05	0.000271	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CG—liver cancer	8.11e-05	0.000269	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MAPK14—liver cancer	7.92e-05	0.000263	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—liver cancer	7.83e-05	0.00026	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—liver cancer	7.77e-05	0.000258	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CD—liver cancer	7.44e-05	0.000247	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—liver cancer	7.43e-05	0.000247	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALB—liver cancer	7.35e-05	0.000244	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMOX1—liver cancer	7.33e-05	0.000243	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CD—liver cancer	7.13e-05	0.000237	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—liver cancer	7.09e-05	0.000235	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALB—liver cancer	7.04e-05	0.000234	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—liver cancer	6.83e-05	0.000227	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CB—liver cancer	6.49e-05	0.000215	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A1—liver cancer	6.48e-05	0.000215	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SERPINE1—liver cancer	6.38e-05	0.000212	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CB—liver cancer	6.21e-05	0.000206	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—liver cancer	6.04e-05	0.0002	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARA—liver cancer	5.92e-05	0.000197	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CG—liver cancer	5.07e-05	0.000168	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—liver cancer	4.9e-05	0.000163	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CD—liver cancer	4.46e-05	0.000148	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALB—liver cancer	4.4e-05	0.000146	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—liver cancer	4.04e-05	0.000134	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—liver cancer	3.96e-05	0.000131	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CB—liver cancer	3.89e-05	0.000129	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—liver cancer	3.79e-05	0.000126	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—liver cancer	3.23e-05	0.000107	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—liver cancer	3.09e-05	0.000103	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—liver cancer	2.8e-05	9.3e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—liver cancer	2.37e-05	7.87e-05	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—liver cancer	1.94e-05	6.43e-05	CbGpPWpGaD
